September 8, 2016

IC Directors’ Meeting Highlights — Thursday, September 8, 2016

Announcements: Francis Collins

Dr. Collins provided an overview of his visits to Perdue University, Northwestern, and the University of Chicago. He also reported on three recent events: the unveiling of the Cancer Moonshot Blue Ribbon Panel report, the workshop on Ensuring Continued Responsible Research with Non-Human Primates, and the Clinical Center Town Hall. Finally, Dr. Collins announced the launch of the NIAID/BARDA Antimicrobial Resistance Prize.

Transition Update: Larry Tabak

Dr. Tabak (DEPD) provided an update on changes to the current guidance for the Presidential transition materials, as well as agency and departmental due dates for the materials.

Minimum Percent Effort/Research Commitment Index: Mike Lauer

Dr. Lauer (DDER) presented on an OER-developed metric to examine how much NIH support is given to individual PIs as part of a broader discussion on the issue of increasing the number of investigators supported by NIH. The presentation was well-received by the IC Directors, who requested a follow up presentation with additional information on the metric’s capabilities and potential uses.

Secondary Assignments: Richard Nakamura

Dr. Nakamura (CSR) provided an overview of, as well as challenges in, the process of determining primary and secondary IC assignments for grant applications or medical conditions with overlapping institutional applicability.

This page last reviewed on November 17, 2016